Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 10/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 8/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 6/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13763582 | 1.00 | KAT8 (0.48) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL4825033 | 1.00 | KAT8 (0.48) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL3188484 | 1.00 | KAT8 (0.48) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL6678627 | 0.99 | KAT8 (0.48) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL6678634 | 0.99 | KAT8 (0.48) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL6679978 | 0.96 | CA1 (0.53) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL6680116 | 0.96 | CA1 (0.53) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL14197585 | 0.96 | CA1 (0.53) | KAT8CA1CA2CA9ALDH1A1 | |
| SCHEMBL10036042 | 0.96 | CA1 (0.53) | KAT8CA1CA2CA9ALDH1A1 | |
| Potassium Ion SCHEMBL6678631 | 0.91 | CA1 (0.48) | KAT8CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1033965-B1 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | WELLA AG (DE) | 2004-11-24 | — | — | EP | claimed |
| EP-0980236-B1 | COLOURANT AND METHOD FOR PRODUCING TEMPORARY HAIR COLOURS | WELLA AG (DE) | 2003-04-23 | — | — | EP | claimed |
| US-6312478-B1 | TWO COMPONENT KIT; ONE COMPONENT IS A COLORANT COMPRISING A MONOMETHINE OR POLYMETHINE DYE; SECOND COMPONENT CONSISTING OF A DECOLORIZING AGENT | WELLA AKTIENGESELLSCHAFT (DE) | 2001-11-06 | — | — | US | claimed |
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-1033965-B1 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | WELLA AG (DE) | 2004-11-24 | — | — | EP | disclosed |
| EP-0980236-B1 | COLOURANT AND METHOD FOR PRODUCING TEMPORARY HAIR COLOURS | WELLA AG (DE) | 2003-04-23 | — | — | EP | disclosed |
| US-6361571-B1 | USING TAUTOMERIC NONOXIDATIVE DYES AND POLYMETHINE DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2002-03-26 | — | — | US | disclosed |
| EP-0549976-B1 | Bleachable antihalation system | STERLING DIAGNOSTIC IMAGING DE (DE) | 1998-02-04 | — | — | EP | disclosed |
| EP-0549976-A1 | Bleachable antihalation system | DU PONT DE NEMOURS (DEUTSCHLAND) GMBH (DE) | 1993-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | SNCA, PSEN1, CDR2 | KAT8 3530/4885CA1 1468/4885CA2 2334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.